A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography
about
Structural basis of transport of lysophospholipids by human serum albuminStructural basis of binding of fluorescent, site-specific dansylated amino acids to human serum albuminCrystallographic analysis reveals the structural basis of the high-affinity binding of iophenoxic acid to human serum albuminA fluorescent fatty acid probe, DAUDA, selectively displaces two myristates bound in human serum albuminStructural Mechanism of Ring-opening Reaction of Glucose by Human Serum AlbuminStructural basis of non-steroidal anti-inflammatory drug diclofenac binding to human serum albuminImmobilised histidine tagged β2-adrenoceptor oriented by a diazonium salt reaction and its application in exploring drug-protein interaction using ephedrine and pseudoephedrine as probesIn silico prediction of human serum albumin binding for drug leads.Challenges and advances in validating enzyme design proposals: the case of kemp eliminase catalysisNonprotein based enrichment method to analyze peptide cross-linking in protein complexes.A novel tumor targeting drug carrier for optical imaging and therapyInteractive association of drugs binding to human serum albumin.Comparison of binding characterization of two antiviral drugs to human serum albumin.Assessment of the interaction procedure between Pt(IV) prodrug [Pt(5,5'-dmbpy)Cl4 and human serum albumin: Combination of spectroscopic and molecular modeling technique.X-ray crystallographic and fluorometric analysis of the interactions of rhein to human serum albumin.X-ray Structure Analysis of Indazolium trans-[Tetrachlorobis(1H-indazole)ruthenate(III)] (KP1019) Bound to Human Serum Albumin Reveals Two Ruthenium Binding Sites and Provides Insights into the Drug Binding Mechanism.QSAR models for the prediction of plasma protein binding.Role of the conformational flexibility of evodiamine in its binding to protein hosts: a comparative spectroscopic and molecular modeling evaluation with rutaecarpine.Human serum albumin: A modulator of cannabinoid drugs.Association of valdecoxib, a nonsteroidal anti-inflammatory drug, with human serum albumin.Confirming therapeutic target of protopine using immobilized β2 -adrenoceptor coupled with site-directed molecular docking and the target-drug interaction by frontal analysis and injection amount-dependent method.HSA-based anti-inflammatory therapy: a new and improved approach.Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients.MegaStokes BODIPY-triazoles as environmentally sensitive turn-on fluorescent dyes
P2860
Q27656406-08B58F7D-CEA5-4169-9189-CA51C10A3E40Q27664984-2C09D50C-C35E-4FC7-9A4B-C15A8EBC21E6Q27667543-7D52798B-1801-43FF-A645-8322A2541450Q27675025-97DAB8A5-8FCE-4043-BC44-E2111E393037Q27677418-751742D8-E611-49E9-9D1E-BF9E76274076Q27700781-78624B23-83D0-4B87-AB54-209988F8B7EFQ28538034-2CD86A3A-7865-4672-A72B-189C8AB8EE2CQ34609144-60D4B6A4-C2F8-4B43-BA36-97F97824E79BQ34917956-B7A09624-073C-4489-AE0B-1DDEC2C363D8Q37396581-BBB3D5A7-C3BD-40C2-82B8-C871F207DC4DQ37695404-F7B4E451-63F0-4189-A56D-2BB6A4E867AFQ38192435-E63DC653-98D1-4FC9-9FA3-39FA9201BE53Q39297626-790654FF-FE7D-4A21-9DBA-0760D2CE8CA5Q39338785-D9FC1490-045D-4DCD-A738-007FD5B5F6B8Q39350813-C0EC54CC-7DFE-4556-A542-E5E175C52217Q39753526-9D27AA9A-EECB-4A13-8953-87345EDAA717Q40552248-AEE6B002-BD7D-45B0-BA00-B1A17413843CQ43815722-EB45B768-40EA-413C-8501-7BD209D50924Q47701321-47BBCD77-FC6C-4623-8B55-7EDFA91B5B8CQ47764363-0D02A2C0-78F3-4941-A9C3-E34B1E259400Q48309880-CABFB411-A799-4521-87EC-72A9707271FDQ49081222-FA6562A2-0F1D-4B90-9AB9-9E28B06FFD4DQ50010598-61DB1041-7A50-4FEB-BE16-690CB71C45C9Q57691887-BE13BE6E-A2AE-4A8A-9D88-FE42F72B8367
P2860
A new drug binding subsite on human serum albumin and drug-drug interaction studied by X-ray crystallography
description
2008 nî lūn-bûn
@nan
2008 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
A new drug binding subsite on ...... udied by X-ray crystallography
@ast
A new drug binding subsite on ...... udied by X-ray crystallography
@en
A new drug binding subsite on ...... udied by X-ray crystallography
@nl
type
label
A new drug binding subsite on ...... udied by X-ray crystallography
@ast
A new drug binding subsite on ...... udied by X-ray crystallography
@en
A new drug binding subsite on ...... udied by X-ray crystallography
@nl
prefLabel
A new drug binding subsite on ...... udied by X-ray crystallography
@ast
A new drug binding subsite on ...... udied by X-ray crystallography
@en
A new drug binding subsite on ...... udied by X-ray crystallography
@nl
P2093
P3181
P1476
A new drug binding subsite on ...... udied by X-ray crystallography
@en
P2093
Edward J Meehan
Liqing Chen
Mingdong Huang
P3181
P356
10.1016/J.JSB.2007.12.004
P577
2008-04-01T00:00:00Z